As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX:AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing.
Apiam Animal Health (ASX:AHX) has been awarded a $700,000 grant to build a new viral vaccine laboratory in Bendigo from the Victorian State Government's Regional Jobs Fund